Memo from White House physician said he and Trump concluded the 'potential benefit' of hydroxychloroquine 'outweighed the relative risks' — despite no clear evidence yet that it works - Creak News

real time news...

Memo from White House physician said he and Trump concluded the 'potential benefit' of hydroxychloroquine 'outweighed the relative risks' — despite no clear evidence yet that it works

Share This

trump white houseDrew Angerer/Getty Images

  • The president's physician said in a memo that he ultimately decided with President Donald Trump that the "potential benefit from treatment outweighed the relative risks" of taking anti-malaria drug hydroxychloroquine as a prophylactic for coronavirus.
  • The memo did not confirm that Trump was taking hydroxychloroquine as he claimed on Monday during a press briefing. Nor did it give more details about its use.
  • Trump told reporters earlier Monday that he has been taking the drug "every day" for the past 10 days as a preventative measure against COVID-19.
  • However, hydroxychloroquine has not been proven to prevent infection. It is currently in clinical trials. Experts have warned against the use of the drug outside of hospital settings and trials.
  • The Food and Drug Administration issued a warning in April about the anti-malaria drug, saying that it can cause irregular heart rhythms in coronavirus patients.
  • Visit Business Insider's homepage for more stories.

A memo from the White House physician said he discussed the benefits and health risks of hydroxychloroquine with President Donald Trump, and they ultimately "concluded the potential benefit from treatment outweighed the relative risks."

The president told reporters earlier Monday that he has been taking hydroxychloroquine — an anti-malaria drug — "every day" for the last 10 days as a preventative measure against COVID-19.

See the rest of the story at Business Insider

NOW WATCH: A cleaning expert reveals her 3-step method for cleaning your entire home quickly

See Also:



from Business Insider https://ift.tt/2WIRY3l

No comments:

Post a Comment

Pages